The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 26, 2017

Filed:

Oct. 29, 2015
Applicant:

Glaxosmithkline Biologicals SA, Rixensart, BE;

Inventors:

Jeannette Adu-Bobie, Siena, IT;

Mariagrazia Pizza, Siena, IT;

Nathalie Norais, Siena, IT;

Germano Ferrari, Ghedi, IT;

Guido Grandi, Siena, IT;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/22 (2006.01); A61K 39/095 (2006.01); C07K 14/245 (2006.01); C12N 9/10 (2006.01); A61K 39/108 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/245 (2013.01); A61K 39/095 (2013.01); C07K 14/22 (2013.01); C12N 9/1051 (2013.01); A61K 39/00 (2013.01); A61K 39/0258 (2013.01);
Abstract

Knockout of the meningococcal mltA homolog gives bacteria that spontaneously release vesicles that are rich in immunogenic outer membrane proteins and that can elicit cross-protective antibody responses with higher bactericidal titers than OMVs prepared by normal production processes. Thus the invention provides a bacterium having a knockout mutation of its mltA gene. The invention also provides a bacterium, wherein the bacterium: (i) has a cell wall that includes peptidoglycan; and (ii) does not express a protein having the lytic transglycosylase activity MltA protein. The invention also provides compositions comprising vesicles that, during culture of bacteria of the invention, are released into the culture medium.


Find Patent Forward Citations

Loading…